Compound 1818
Identifiers
- Canonical SMILES:
CCOc1cc(cc(c1)-c1c(C)noc1C)C(C)=O
- IUPAC name:
1-[3-(3,5-dimethyl-1,2-oxazol-4-yl)-5-ethoxyphenyl]ethan-1-one
- InChi:
InChI=1S/C15H17NO3/c1-5-18-14-7-12(10(3)17)6-13(8-14)15-9(2)16-19-11(15)4/h6-8H,5H2,1-4H3
- InChiKey:
MFVHCTKKQRFPQC-UHFFFAOYSA-N
External links
![]() 54757752 |
![]() CHEMBL1828985 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
3 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
Bromodomain / Histone | 5.64 | breast cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 259.12 g/mol | |||
HBA | 4 | |||
HBD | 0 | |||
HBA + HBD | 4 | |||
AlogP | 2.07 | |||
TPSA | 52.33 | |||
RB | 4 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 3 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
10.1021/jm200640v | 4c | CBP Q92793 |
H4 P62805 |
Biochemical assay | alphascreen BRD4 | pIC50 (half maximal inhibitory concentration, -log10) | 5.12 | |
10.1021/jm200640v | 4c | CBP Q92793 |
H4 P62805 |
Biochemical assay | alphascreen BRD2 | pIC50 (half maximal inhibitory concentration, -log10) | 5.64 | |
10.1021/jm200640v | 4c | CBP Q92793 |
H4 P62805 |
Biochemical assay | alphascreen CREBBP | pIC50 (half maximal inhibitory concentration, -log10) | 4.89 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.5000 | Valdecoxib | DB00580 | |
0.4483 | AUY922 | DB11881 | |
0.4478 | Parecoxib | DB08439 | |
0.4450 | 5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-(4-METHOXYPHENYL)ISOXAZOLE-3-CARBOXAMIDE | DB06964 | |
0.4433 | Alobresib | DB14970 | |
0.4398 | PX-102 | DB15416 | |
0.4219 | 5-(3-{3-[3-HYDROXY-2-(METHOXYCARBONYL)PHENOXY]PROPENYL}PHENYL)-4-(HYDROXYMETHYL)ISOXAZOLE-3-CARBOXYLIC ACID | DB08001 | |
0.4091 | 2,6-DIMETHYL-1-(3-[3-METHYL-5-ISOXAZOLYL]-PROPANYL)-4-[2-METHYL-4-ISOXAZOLYL]-PHENOL | DB08715 | |
0.4038 | 5-(5-chloro-2,4-dihydroxyphenyl)-N-ethyl-4-[4-(morpholin-4-ylmethyl)phenyl]isoxazole-3-carboxamide | DB06961 | |
0.3876 | Iloperidone | DB04946 | |
0.3795 | 2,6-DIMETHYL-1-(3-[3-METHYL-5-ISOXAZOLYL]-PROPANYL)-4-[2N-METHYL-2H-TETRAZOL-5-YL]-PHENOL | DB08713 | |
0.3737 | 5-(2-Fluoro-5-{(1E)-3-[3-hydroxy-2-(methoxycarbonyl)phenoxy]-1-propen-1-yl}phenyl)-1,2-oxazole-3-carboxylic acid | DB02014 | |
0.3702 | 4-(1,3-Benzodioxol-5-Yl)-5-(5-Ethyl-2,4-Dihydroxyphenyl)-2h-Pyrazole-3-Carboxylic Acid | DB02840 | |
0.3681 | CCT-018159 | DB07594 | |
0.3678 | (E)-[4-(3,5-Difluorophenyl)-3H-pyrrolo[2,3-b]pyridin-3-ylidene](3-methoxyphenyl)methanol | DB07840 |